Putative novel CSF biomarkers of Alzheimer's disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort

Transl Neurodegener. 2024 Mar 8;13(1):14. doi: 10.1186/s40035-024-00405-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alzheimer Disease* / diagnosis
  • Amyloid beta-Peptides
  • Biomarkers
  • Humans
  • tau Proteins

Substances

  • Amyloid beta-Peptides
  • tau Proteins
  • Biomarkers